$3.660
-0.286 (-7.81%)收盤時
XAIR 資訊
XAIR 事件
Beyond Air's LungFit GO Receives FDA Breakthrough Device Designation
Beyond Air announced that the FDA has granted Breakthrough Device Designation to LungFit GO for the treatment of nontuberculous mycobacterial pulmonary disease.
Beyond Air Enters Acquisition Agreement with Univo for NeuroNOS
Beyond Air announced that they have entered into a definitive agreement under which Univo Pharmaceutical Industries will acquire control over the outstanding shares of NeuroNOS Israel. The transaction is intended to provide NeuroNOS with dedicated resources, funding and strategic focus. Currently, Beyond Air, through its wholly owned Irish subsidiary, NeuroNOS Limited, holds 5M ordinary shares of NeuroNOS, representing approximately 58% of NeuroNOS's issued share capital on a fully diluted basis. Upon closing, Univo will purchase NeuroNOS Limited's entire stake in NeuroNOS pursuant to a share purchase agreement among Beyond Air, NeuroNOS Limited and Univo. In exchange, Beyond Air will receive Univo ordinary shares representing 19.99% of Univo's issued and outstanding share capital, together with warrants to purchase additional Univo ordinary shares representing 19.99% of Univo's total outstanding options, warrants and other awards, exercisable at $0.01 per share for five years following closing. Separately, under an intellectual property transfer agreement between Beyond Air and NeuroNOS Beyond Air will transfer to NeuroNOS certain intellectual property rights and other assets relating to NeuroNOS's development programs, in consideration for development and commercial milestone payments up to $6.5M in cash development milestone payments tied to the clinical advancement, regulatory approval and commercialization of a therapeutic product based on NeuroNOS intellectual property. Beyond Air will also be eligible to receive up to $26M in additional commercial milestone payments upon achievement of specified net sales thresholds. The transaction is expected to close following satisfaction of the conditions set forth in the definitive agreement, including applicable board and shareholder approvals, regulatory and stock exchange approvals, completion of the contemplated investment and other customary closing conditions.
Beyond Air Trading Halted, News Pending
Beyond Air trading halted, news pending
Dow Jones Falls 44.51 Points Amid Weakness in Tech Stocks
The major averages closed fractionally lower amid another wave of weakness hitting large-cap technology and semiconductor stocks. Of note, President Donald Trump in a social media post threatened a 100% tariff on European countries imposing a digital services tax on American companies.Outside of technology, falling oil prices are acting as a stabilizing force. Crude has moved toward multi-month lows as supply concerns continue easing, helping reduce some inflation pressure and potentially improving the broader economic outlook.Meanwhile, President Trump said on Truth Social that Iran shot "at least four" drones at ships crossing the Strait of Hormuz, with the president saying the U.S. "knocked down" three drones, while one of the drones "solidly" hit the upper deck of a large cargo ship. The drone attacks were "a foolish violation" of the countries' ceasefire agreement, he added.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:On SemiSynapticsin a $7B all-stock transactionFedEx FreightreportedOpenAI is leaning toward waiting until next year for its IPO,Troy Rohrbaugh has become the leading contender to succeed Jamie Dimon as CEO of JPMorgan,Qualcommexecutive vice president Durga Malladithat the company plans to use the new chip technology it created for data centers in smartphones2. WALL STREET CALLS:KeyBancNikeon longer than expected turnaroundCrocsto Overweight at Piper SandlerRobinhoodwith a Buy at BTIGAMHto Outperform at BMO CapitalVisteonto Neutral at Baird3. AROUND THE WEB:Boeinghas secured a $3.62B order from China Southern Airlines for freighter aircraft, including two 777F and five 777-8F models, along with options for three additional 777-8Fs, Bloomberg reportsUnileveris exploring a bid for Thorne, the supplements maker valued at up to $4B, and is among several bidders circling the brand, which has been put up for sale by its private equity owner L Catterton, FT reportsMetais working to replace human moderation with generative AI, FT saysGoogleis asking publishers that test new AI features in Google News to grant it broad rights to their content, including to potentially train AI models, The Information reportsVolkswagenCEO Oliver Blume is targeting a major restructuring that could include cutting up to 100,000 jobs, closing four German plants, and reducing planned five-year investment by about 15% to just over EUR130B, Reuters reports4. MOVERS:FuelCellincreased after Jefferiesthe stock to BuyAcadia Pharmaceuticalsgained after announcing Daybu wasin the EU by CHMPInfleqtionwas higher after Wedbushcoverage of the stock with an Outperform ratingBraksemwas lower in New York after filing for anCapricorfell afterfrom its HOPE-2 open-label extension study and announcing the FDA is planning to convene an advisory committee meeting to discuss the company's BLA for Deramiocel5. EARNINGS/GUIDANCE:Beyond Airand narrowed its guidance for FY26American Outdoor Brands, with CEO Brian Murphy commenting, "we are encouraged by the strength of our brands and the favorable consumer demand reflected in our POS results"Wisereportedand provided guidance for FY27Cineverse, with EPS and revenue higher year-over-yearApogee Enterprises, with CEO Donald Nolan commenting, "Our results for the quarter reflect solid execution as our team effectively navigated a dynamic operating environment"INDEXES:The Dow fell 44.51, or 0.086%, to 51,876.11, the Nasdaq lost 60.99, or 0.24%, to 25,297.62, and the S&P 500 declined 3.47, or 0.047%, to 7,354.02.
Major Averages Edge Higher as Tech Stocks Weaken
The major averages were fractionally higher near noon despite another wave of weakness hitting large-cap technology and semiconductor stocks. Outside of technology, falling oil prices are acting as a stabilizing force. Crude has moved toward multi-month lows as supply concerns continue easing, helping reduce some inflation pressure and potentially improving the broader economic outlook.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:On SemiSynapticsin a $7B all-stock transactionFedEx FreightreportedOpenAI is leaning toward waiting until next year for its IPO,Troy Rohrbaugh has become the leading contender to succeed Jamie Dimon as CEO of JPMorgan,Rocket Labwas selected by NASA tofor two separate NASA missions - PolSIR and TSIS-2 - from early next year2. WALL STREET CALLS:KeyBancNikeon longer than expected turnaroundCrocsto Overweight at Piper SandlerRobinhoodwith a Buy at BTIGAMHto Outperform at BMO CapitalVisteonto Neutral at Baird3. AROUND THE WEB:Boeinghas secured a $3.62B order from China Southern Airlines for freighter aircraft, including two 777F and five 777-8F models, along with options for three additional 777-8Fs, Bloomberg reportsUnileveris exploring a bid for Thorne, the supplements maker valued at up to $4B, and is among several bidders circling the brand, which has been put up for sale by its private equity owner L Catterton, FT reportsMetais working to replace human moderation with generative AI, FT saysGoogleis asking publishers that test new AI features in Google News to grant it broad rights to their content, including to potentially train AI models, The Information reportsVolkswagenCEO Oliver Blume is targeting a major restructuring that could include cutting up to 100,000 jobs, closing four German plants, and reducing planned five-year investment by about 15% to just over EUR 130B, Reuters reports4. MOVERS:FuelCellincreases after Jefferiesthe stock to BuyAcadia Pharmaceuticalsgains after announcing Daybu wasin the EU by CHMPInfleqtionhigher after Wedbushof the stock with an Outperform ratingBraksemlower in New York after filing for anfrom creditorsCapricor (CAPR) falls after presentingfrom its HOPE-2 open-label extension study and announcing the FDA is planning to convene an advisory committee meeting to discuss the company's BLA for Deramiocel5. EARNINGS/GUIDANCE:Beyond Airand narrowed its guidance for FY26American Outdoor Brands, with CEO Brian Murphy commenting, "we are encouraged by the strength of our brands and the favorable consumer demand reflected in our POS results"Wiseand provided guidance for FY27Cineverse, with EPS and revenue higher year-over-yearApogee Enterprises (APOG), with CEO Donald Nolan commenting, ""Our results for the quarter reflect solid execution as our team effectively navigated a dynamic operating environment"INDEXES:Near midday, the Dow was up 0.23%, or 118.98, to 52,039.60, the Nasdaq was up 0.22%, or 56.16, to 25,414.76, and the S&P 500 was up 0.24%, or 17.60, to 7,375.09.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。